RETRACTED: Lokanath et al. Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights. Drugs Drug Candidates 2025, 4, 16

The journal retracts the article titled “Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights” [1], cited above.

Following publication, concerns were raised relating to an unauthorized use of software utilized to generate and analyze a portion of the data presented in this study [1].

Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board, which confirmed that the data contained in this article is subject to an intellectual property agreement, and that the authors did not receive appropriate permission for publication. As retroactive permission could not be gained from the intellectual property rights holder, the Editorial Office, the Editorial Board, and the authors have decided to retract this article as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 18 December 2025) and in line with the Committee on Publication Ethics (COPE)’s retraction guidelines.

This retraction was approved by the Editor-in-Chief of the journal Drugs and Drug Candidates.

The author agrees with this decision.